{"id":"https://openalex.org/W2906845037","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.e18027","title":"Impact of early responses in the outcome of patients with newly diagnosed CML-CP, evaluated by FISH in countries where standard cytogenetics are not available or reliable.","display_name":"Impact of early responses in the outcome of patients with newly diagnosed CML-CP, evaluated by FISH in countries where standard cytogenetics are not available or reliable.","publication_year":2014,"publication_date":"2014-05-20","ids":{"openalex":"https://openalex.org/W2906845037","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.e18027","mag":"2906845037"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.15_suppl.e18027","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.e18027","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.e18027","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2906845037"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060691458","display_name":"Christianne Bourlon","orcid":"https://orcid.org/0000-0002-6284-6269","observed_orcids":["https://orcid.org/0000-0002-6284-6269"]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Christianne Bourlon","raw_affiliation_strings":["Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210097900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083187405","display_name":"C. F. Hernandez Mata","orcid":"https://orcid.org/0000-0002-4784-7247","observed_orcids":["https://orcid.org/0000-0002-4784-7247"]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Carlos Francisco Hernandez-Mata","raw_affiliation_strings":["Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210097900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003919218","display_name":"Maria Teresa Bourlon","orcid":"https://orcid.org/0000-0002-3116-912X","observed_orcids":["https://orcid.org/0000-0002-3116-912X"]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Maria Teresa Bourlon","raw_affiliation_strings":["Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210097900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027170167","display_name":"Elena Juventina Tuna-Aguilar","orcid":"https://orcid.org/0000-0001-8130-6463","observed_orcids":["https://orcid.org/0000-0001-8130-6463"]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Elena Tuna-Aguilar","raw_affiliation_strings":["Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210097900"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110317452","display_name":"\u00c1lvaro Aguayo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Alvaro Aguayo","raw_affiliation_strings":["Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubiran, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubiran, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210097900"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210097900"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"15_suppl","first_page":"e18027","last_page":"e18027"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.8450000286102295},{"id":"https://openalex.org/keywords/chronic-phase","display_name":"chronic phase","score":0.8029999732971191},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.9359999895095825},{"id":"https://openalex.org/keywords/fluorescence-in-situ-hybridization","display_name":"fluorescence in situ hybridization","score":0.8220000267028809},{"id":"https://openalex.org/keywords/karyotype","display_name":"karyotype","score":0.7260000109672546},{"id":"https://openalex.org/keywords/complete-cytogenetic-response","display_name":"complete cytogenetic response","score":0.9580000042915344},{"id":"https://openalex.org/keywords/treatment-response-monitoring","display_name":"treatment response monitoring","score":0.8080000281333923},{"id":"https://openalex.org/keywords/prognostic-value","display_name":"prognostic value","score":0.6769999861717224},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.460999995470047},{"id":"https://openalex.org/keywords/latin-america","display_name":"Latin America","score":0.7110000252723694},{"id":"https://openalex.org/keywords/bcr-abl1","display_name":"BCR-ABL1","score":0.37599998712539673},{"id":"https://openalex.org/keywords/philadelphia-chromosome","display_name":"Philadelphia chromosome","score":0.30300000309944153},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.3970000147819519},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.46700000762939453},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8130000233650208},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.7699999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8563555479049683},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6603597402572632},{"id":"https://openalex.org/C2909208804","wikidata":"https://www.wikidata.org/wiki/Q127282","display_name":"Fish <Actinopterygii>","level":2,"score":0.4786226153373718},{"id":"https://openalex.org/C66339696","wikidata":"https://www.wikidata.org/wiki/Q6089397","display_name":"Log-rank test","level":3,"score":0.46266722679138184},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.4386654496192932},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.43616488575935364},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4301438629627228},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3388238549232483},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32429373264312744},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.2886865735054016},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08986315131187439},{"id":"https://openalex.org/C505870484","wikidata":"https://www.wikidata.org/wiki/Q180538","display_name":"Fishery","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.15_suppl.e18027","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.e18027","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.e18027","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2417014944","https://openalex.org/W2595791487","https://openalex.org/W2531275941","https://openalex.org/W2585259379","https://openalex.org/W1997627095","https://openalex.org/W2535243513","https://openalex.org/W2149328712","https://openalex.org/W2093986644","https://openalex.org/W2587265177","https://openalex.org/W2138768865"],"abstract_inverted_index":{"e18027":[0],"Background:":[1],"Imatinib":[2],"(IM)":[3],"achieves":[4],"complete":[5],"cytogenetic":[6],"response":[7,19,270,349],"(CCyR)":[8],"in":[9,56,79,173,177,183,200,205,209,225,241,286,332,354],"87%":[10],"of":[11,32,87,108,326,328],"chronic":[12,14],"phase":[13],"myeloid":[15],"leukemia":[16],"(CML-CP).":[17],"Monitoring":[18],"is":[20,27,36,41,54,91,330],"fundamental,":[21],"not":[22,282],"achieving":[23],"CCyR":[24,238,293,382],"at":[25,58,62,114,122,190,243,246,249,253,265,275,298,307,350,369,383],"12m":[26,250],"associated":[28,358],"to":[29,112],"higher":[30],"rates":[31],"progression.":[33],"Karyotype":[34],"(KT)":[35],"standard":[37],"for":[38,230,316,336,389],"monitoring,":[39],"FISH":[40,74,181,208,220,274,348,368],"an":[42,374],"alternative":[43],"method,":[44],"few":[45],"studies":[46],"have":[47],"correlated":[48],"both.":[49],"In":[50,322,338],"Latin":[51],"America":[52],"monitoring":[53,125,376],"done":[55,199],"31%":[57],"3m":[59,299],"and":[60,67,75,89,124,133,136,142,175,188,195,207,219,251,258,263,279,306,319,352,371,378],"54%":[61],"6m,":[63,247],"72%":[64],"by":[65,139,273],"KT":[66,82,132,179,197,218,329],"19%":[68],"FISH.":[69,337],"No":[70],"study":[71],"has":[72,83],"validated":[73],"its":[76],"prognostic":[77],"value":[78],"countries":[80],"were":[81,117,126,146,166,260],"a":[84,341,381],"high":[85,176,342],"rate":[86,325],"failure":[88,327],"there":[90],"no":[92],"standardized":[93],"PCR.":[94],"Methods:":[95],"Patients":[96,290],">18y":[97],"with":[98,106,154,227,334,359],"CML-CP":[99],"on":[100],"IM":[101],"400mg":[102],"as":[103,373],"frontline":[104],"therapy":[105,390],"18m":[107,280],"follow-up":[109,235],"from":[110],"2003":[111],"2012":[113],"our":[115,323,355],"institution":[116],"included.":[118],"Clinical":[119],"data,":[120],"citogenetics":[121],"diagnosis":[123],"collected":[127],"retrospectively.":[128],"Pearson":[129,215],"correlation":[130,216,343],"between":[131,217],"FISH,":[134],"survival":[135],"time-to-event":[137],"curves":[138],"Kaplan-Meir":[140],"method":[141],"log":[143],"rank":[144],"test":[145],"performed.":[147],"Results:":[148],"We":[149],"found":[150],"73":[151],"(84%)":[152],"patients":[153,379],"CML-CP,":[155],"65":[156],"fulfilled":[157],"inclusion":[158],"criteria.":[159],"Median":[160,234],"age":[161],"38y,":[162],"56%":[163],"male,":[164],"83%":[165],"symptomatic.":[167],"EUTOS":[168],"risk":[169],"score":[170],"was":[171,198,221,236,239,346,357],"low":[172],"66%":[174,252],"27%.":[178],"and/or":[180],"available":[182],"100,":[184],"47,":[185],"84,":[186],"84":[187],"76%":[189],"diagnosis,":[191],"3,":[192,276],"6,":[193,277],"12":[194,278],"18m.":[196],"223":[201],"samples":[202,211,226,340],"reported":[203,212],"successful":[204,213,228,339],"37%":[206],"236":[210],"92%.":[214],"0.98":[222],"(CI95%":[223],"0.97-0.99)":[224],"reports":[229],"both":[231],"tests":[232,345],"(n=121).":[233],"61m.":[237],"obtained":[240],"27%":[242],"3m,":[244],"43%":[245],"61%":[248],"18":[254],"m.":[255],"OS,":[256],"EFS":[257,297],"TFS":[259],"87,":[261],"78":[262],"64%":[264],"5":[266],"years.":[267],"Difference":[268],"among":[269,344],"groups":[271],"evaluated":[272],"did":[281],"reach":[283],"significant":[284],"difference":[285],"OS":[287],"or":[288],"TFS.":[289],"who":[291],"achieved":[292],"had":[294],"significantly":[295],"better":[296,360],"100":[300,310],"vs":[301,303,311,313],"94":[302],"33%":[304,314],"(<0.001)":[305,315],"6":[308],"months":[309],"50":[312],"CCyR,":[317],"PCyR":[318],"MinCyR.":[320],"Conclusions:":[321],"series":[324],"62%":[331],"contrast":[333],"7%":[335],"found.":[347],"3":[351,370],"6m":[353,372],"cohort":[356],"EFS.":[361],"Given":[362],"this":[363],"data":[364],"we":[365],"suggest":[366],"using":[367],"acceptable":[375],"test,":[377],"lacking":[380],"these":[384],"times":[385],"might":[386],"be":[387],"candidates":[388],"modifications.":[391]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-01-11T00:00:00"}